Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Thorax”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03352245
What this trial is testing

Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer

Who this might be right for
Lung Neoplasm Malignant
Yale University 40
Testing effectiveness (Phase 2)Study completedNCT00030745
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 61
Early research (Phase 1)WithdrawnNCT04201145
What this trial is testing

Pembrolizumab + Defactinib In Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Raphael Bueno, MD
Early research (Phase 1)Study completedNCT01999985
What this trial is testing

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute 25
Not applicableUnknownNCT02891642
What this trial is testing

Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid

Who this might be right for
MalignancyPleural EffusionPleural Diseases+1 more
The First Affiliated Hospital with Nanjing Medical University 1,000
Very early researchLooking for participantsNCT04684459
What this trial is testing

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

Who this might be right for
Peritoneal Carcinoma MetastaticPleural Effusion, MalignantHER2 Positive Malignancies
Sichuan University 18
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)UnknownNCT02657460
What this trial is testing

Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion

Who this might be right for
Malignant Pleural Effusion
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 90
Testing effectiveness (Phase 2)Study completedNCT06208124
What this trial is testing

IMM-6-415 in RAS/RAF Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumor (Phase 1)Pancreas AdenocarcinomaNon-small Cell Lung Cancer+1 more
Immuneering Corporation 30
Testing effectiveness (Phase 2)Study completedNCT00309946
What this trial is testing

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 51
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Not applicableUnknownNCT05935696
What this trial is testing

A Prospective Observational Study on the Role of Transthoracic Ultrasound in Differentiating Tuberculous From Malignant Pleural Effusion

Who this might be right for
Pleural EffusionTuberculosis, PleuralMalignant Pleural Effusion
Sarawak General Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT00402896
What this trial is testing

Malignant Pleural Effusion With ZD6474

Who this might be right for
Lung CancerPleural Effusion
M.D. Anderson Cancer Center 28
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Not applicableUnknownNCT04263688
What this trial is testing

Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural Effusion

Who this might be right for
Non-Small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease 300
Early research (Phase 1)Looking for participantsNCT05092373
What this trial is testing

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Who this might be right for
Advanced Breast CarcinomaAdvanced Endometrial CarcinomaAdvanced Fallopian Tube Carcinoma+71 more
M.D. Anderson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT00054002
What this trial is testing

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Roswell Park Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT04177953
What this trial is testing

Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery

Who this might be right for
Pleural Mesothelioma Malignant
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT06155279
What this trial is testing

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

Who this might be right for
Pleural Mesothelioma
Istituto Oncologico Veneto IRCCS 41
Early research (Phase 1)Ended earlyNCT06091930
What this trial is testing

Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6

Who this might be right for
Gastrointestinal CancerLung CancerPancreatic Cancer+3 more
Boehringer Ingelheim 21
Next Page